Please login to the form below

Not currently logged in
Email:
Password:

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

Treato Gregory GalloIsrael-based Treato has appointed Gregory Gallo as its new chief commercial officer.

Working out of the online healthcare consumer insights firm's Princeton, New Jersey office, Gallo will be responsible for leading its business solutions unit as well as expanding the firm's global presence in the pharmaceutical industry.

Ido Hadari, Treato's chief executive officer, said: “Greg has a remarkable track record in helping build, lead and scale innovative businesses.

“We are excited to have Greg join our leadership team and look forward to benefitting from his vast knowledge and commercial experience in the healthcare data and analytics field.”

Gallo has over 20 years of commercial experience in the healthcare and pharmaceutical industries, having held senior roles at IntelliSante, ImpactRX, Johnson & Johnson and Quest Diagnostics.

He joins Treato from Activate Networks, now a part of Decision Resources Group, where he served as chief commercial officer and oversaw its commercial operations and growth.

12th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics